The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity

The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity

O-1602 and O-1918 are atypical cannabinoid ligands for GPR55 and GPR18, which may be novel pharmaceuticals for the treatment of obesity by targeting energy homeostasis regulation in skeletal muscle. This study aimed to determine the effect of O-1602 or O-1918 on markers of oxidative capacity and fat...

Full description

Bibliographic Details
Main Authors: Anna C. Simcocks, Lannie O’Keefe, Kayte A. Jenkin, Lauren M. Cornall, Esther Grinfeld, Michael L. Mathai, Deanne H. Hryciw, Andrew J. McAinch
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:International Journal of Molecular Sciences
Subjects:
Atypical Cannabinoids
O-1602
O-1918
GPR18
obesity and skeletal muscle
Online Access:https://www.mdpi.com/1422-0067/21/16/5922

Internet

https://www.mdpi.com/1422-0067/21/16/5922

Similar Items